NCI Immunotherapy Fellowship

One Year at NIH Clinical Center • Begins July 2022
Application Period: 8/5/2021-9/15/2021

Conducted at the NCI's Center for Cancer Research in Bethesda, Md., this 1-year program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy. This fellowship provides opportunities to understand how to design, write and run clinical trials, how to treat patients, how manage toxicities, as well as opportunities to work with multiple experimental agents.

Eligibility Criteria

• Able to relocate to Bethesda, Md., for the duration of the fellowship
• Trained in Medical Oncology, Hematology, Pediatric Oncology, Radiation Oncology, or Surgical Oncology
• Interest in learning about immunotherapy
• Preference is given to those with an academic interest
• Open to U.S. and Non-U.S. trained physicians
• If trained outside of North America, ECFMG certification and USMLE steps 1, 2 and 3

Benefits

• Provides opportunities to understand how to design, write, and run clinical trials, how to treat patients, how to manage toxicities, as well as opportunities to work with multiple experimental agents
• Work with internationally recognized experts in immunotherapy
• Learn management of immune-related adverse events
• Develop experience in writing and running immunotherapy clinical trials
• Develop experience with a wide array of immunotherapy approaches
  • Cellular therapy (e.g., CAR-T or TCR transgenic approaches)
  • Combination immunotherapy approaches
  • Immune checkpoint inhibitors
  • Immunocytokines
  • Therapeutic vaccines
• Possibilities for attending and presenting at national/international meetings
• Attend and participate in regularly scheduled NIH immunotherapy conferences
• Make a difference in the lives of patients with cancer at the largest hospital in the world devoted solely to research
• Salary is based on applicable laws, regulations, and policies